News
Bayer partners with Kumquat Biosciences to advance a promising Kras G12D cancer treatment, aiming to address critical unmet ...
SamaCare announced that it is officially ranked on Inc. ’s annual 5,000 list. 1 The cloud-based patient access platform for ...
Vor Bio appoints Dallan Murray as chief commercial officer, leveraging his extensive experience to drive commercialization ...
Cardinal Health's Specialty Alliance will acquire Solaris Health for $1.9 billion, enhancing its urology capabilities. The ...
Brinsupri is a first-in-class DPP1 inhibitor that has been found to inhibit activation of neutrophil enzymes that drive chronic airway inflammation in non-cystic fibrosis bronchiectasis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results